Clinical Trial Update: Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating tucidinostat and fulvestrant in hormone-receptor positive advanced breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fulvestrant (fulvestrant)
• Tucidinostat (tucidinostat)

Snippet

Sponsor: Guangdong Women and Children Hospital | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN